NET CONNECT Update from ASCO, AACR and WCGIC 2020
NET CONNECT has summarised highlights from ASCO 2020, AACR 2020 and WCGIC 2020 virtual meetings for you
Highlights from the abstracts: Efficacy and safety of surufatinib (ASCO), AGITG control NET Study (ASCO), DNA-PK inhibitor, M3814 (AACR) and Young adults with neuroendocrine tumours present high rate of pathogenic germline variants in cancer predisposing genes (WCGIC) by Dr. Aman Chauhan, University of Kentucky’s Markey Cancer Center, (NCI Designated Cancer Center), Kentucky, USA
DOWNLOAD THE SLIDES
Please respond on a scale of 1 to 5 (5=strongly agree).